Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Cipher Pharmaceuticals Announces Plans to Voluntarily Delist from NASDAQ PR Newswire MISSISSAUGA, ON, Nov. 29, 2016 MISSISSAUGA, ON, Nov. 29, 2016 /PRNewswire/ - Cipher Pharmaceuticals Inc...
Cipher Pharmaceuticals Reports Q3 2016 Financial Results PR Newswire MISSISSAUGA, ON, Nov. 11, 2016 MISSISSAUGA, ON, Nov. 11, 2016 /PRNewswire/ - Cipher Pharmaceuticals Inc. (NASDAQ:CPHR;...
Cipher Pharmaceuticals Announces Management Change PR Newswire MISSISSAUGA, ON, Nov. 11, 2016 MISSISSAUGA, ON, Nov. 11, 2016 /PRNewswire/ - Cipher Pharmaceuticals Inc. (NASDAQ:CPHR; TSX:CPH...
Oracle Completes Tender Offer for Acquisition of NetSuite Deal to Close Monday PR Newswire REDWOOD SHORES, Calif., Nov. 5, 2016 REDWOOD SHORES, Calif., Nov. 5, 2016 /PRNewswire/ -- Oracle...
Cipher Pharmaceuticals Responds to Request for Comment from IIROC PR Newswire MISSISSAUGA, ON, Oct. 31, 2016 MISSISSAUGA, ON, Oct. 31, 2016 /PRNewswire/ - Cipher Pharmaceuticals Inc...
NetSuite Appoints Sam Levy As Vice President Of Sales Americas PR Newswire SAN MATEO, Calif., Oct. 25, 2016 SAN MATEO, Calif., Oct. 25, 2016 /PRNewswire/ -- NetSuite Inc. (NYSE: N), the...
NetSuite Announces Third Quarter 2016 Financial Results PR Newswire SAN MATEO, Calif., Oct. 21, 2016 SAN MATEO, Calif., Oct. 21, 2016 /PRNewswire/ -- NetSuite Inc. (NYSE: N), the industry's...
Minds&More Drives Growth And Efficiency With NetSuite Services Resource Planning NetSuite SRP Replaces Multiple Systems at Belgian Consultancy PR Newswire LONDON, Oct. 11, 2016 LONDON, Oct...
Europe Watch Group Selects NetSuite OneWorld To Power International Growth PR Newswire LONDON, Oct. 11, 2016 Global Distributor of CLUSE and Cortese Timepieces Replaces Entry...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
